People

Jill Milne joined Gensaic’s board in June 2026. She co-founded Catabasis Pharmaceuticals and previously served as its CEO and as president and CEO of Astria Therapeutics. She brings scientific, operational and public-company leadership experience to Gensaic’s cardiometabolic and RNAi programs.